Richter expects 5% decline in revenue
Image by gedeonrichter.com
Hungarian drugmaker Gedeon Richter foresees a 5% drop in its revenue this year, calculated in euros, CEO Erik Bogsch said this morning at a press conference during which the company presented its Q4 earnings report, according to reports.
According to Bogsch, the company projects a decline in sales in Ukraine and other CIS countries, as well as in Eastern Europe and the United States, however, he expects higher turnover in Western Europe, China and Latin America, according to Hungarian news agency MTI.
Calculated in rubles, Richter’s revenue in Russia could edge up, despite the weakening of the currency, which is expected to have a significant impact on Richter’s results, Bogsch said. He added that last yearʼs results were excellent, helped by higher turnover, lower costs, narrower financial losses and a low base, MTI reported.
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.